Share on StockTwits

Shares of Bio-Reference Laboratories (NASDAQ:BRLI) gapped up prior to trading on Wednesday following a stronger than expected earnings report, Analyst RN reports. The stock had previously closed at $31.81, but opened at $32.08. Bio-Reference Laboratories shares last traded at $32.37, with a volume of 156,264 shares traded.

The company reported $0.55 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.53 by $0.02. The company had revenue of $222.10 million for the quarter, compared to the consensus estimate of $210.44 million. During the same quarter last year, the company posted $0.53 earnings per share. Bio-Reference Laboratories’s revenue was up 19.8% compared to the same quarter last year.

The stock has a 50-day moving average of $31.36 and a 200-day moving average of $28.41. The company has a market cap of $894.9 million and a price-to-earnings ratio of 22.91.

Bio-Reference Laboratories, Inc (NASDAQ:BRLI) is a clinical testing laboratory offering testing, information and related services to physician offices, clinics, hospitals, employers and governmental units.

Receive News & Ratings for Bio-Reference Laboratories Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Reference Laboratories Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.